Xinzheng Li
No. 382 Wuyi Road
Taiyuan, 030001, China
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A combined model of ultrasound viscoelasticity and inflammatory indices for differentiating benign and malignant breast lesions.
Journal: BMC medical imaging
Published: September 25, 2025
ST6GAL1 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer via the HIF-HK2 Signaling Pathway.
Journal: Breast cancer (Dove Medical Press)
Published: July 23, 2025
Microbial community profiles in breast cancer and normal adjacent tissues: associations with clinicopathological characteristics.
Journal: Translational cancer research
Published: July 19, 2025
Down-Regulation of lncRNA CKMT2-AS1 Predicts Poor Prognosis and Promotes Breast Cancer Progression.
Journal: Breast cancer (Dove Medical Press)
Published: June 18, 2025
Exportin-T Promotes Breast Cancer Progression via PI3K/AKT/mTOR Signaling Pathway.
Journal: Journal of inflammation research
Published: January 16, 2025
Construction and evaluation of a prognostic model for breast cancer based on aging related genes.
Journal: Scientific reports
Published: August 18, 2024
Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker Analysis.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 21, 2023
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China.
Journal: JMIR public health and surveillance
Published: January 25, 2023
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 11, 2020
Comprehensive analysis of prognosis-related methylated sites in breast carcinoma.
Journal: Molecular genetics & genomic medicine
Published: July 09, 2019
Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: February 09, 2017
Last Updated: 09/26/2026